InfuSystem (NYSE:INFU) Raised to “Strong-Buy” at StockNews.com

InfuSystem (NYSE:INFU) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Friday.

Separately, B. Riley started coverage on shares of InfuSystem in a report on Thursday, September 26th. They set a “buy” rating and a $13.00 target price on the stock.

InfuSystem Trading Up 6.4 %

Shares of INFU stock traded up $0.47 during trading hours on Friday, reaching $7.81. The stock had a trading volume of 102,498 shares, compared to its average volume of 47,135. The stock has a fifty day simple moving average of $6.59. The firm has a market capitalization of $166.51 million, a price-to-earnings ratio of 781.78 and a beta of 1.45. The company has a quick ratio of 1.64, a current ratio of 2.07 and a debt-to-equity ratio of 0.64. InfuSystem has a 12 month low of $5.74 and a 12 month high of $10.99.

InfuSystem (NYSE:INFU) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). InfuSystem had a return on equity of 0.70% and a net margin of 0.28%. The company had revenue of $33.70 million during the quarter. As a group, equities research analysts anticipate that InfuSystem will post 0.17 EPS for the current fiscal year.

Institutional Trading of InfuSystem

Several large investors have recently modified their holdings of INFU. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of InfuSystem during the third quarter valued at about $87,000. Oppenheimer Asset Management Inc. lifted its stake in shares of InfuSystem by 28.0% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 33,337 shares of the company’s stock valued at $223,000 after purchasing an additional 7,295 shares during the period. GSA Capital Partners LLP lifted its stake in shares of InfuSystem by 23.9% in the 3rd quarter. GSA Capital Partners LLP now owns 65,680 shares of the company’s stock valued at $440,000 after purchasing an additional 12,657 shares during the period. Greenwood Capital Associates LLC raised its holdings in InfuSystem by 14.0% in the third quarter. Greenwood Capital Associates LLC now owns 119,062 shares of the company’s stock worth $798,000 after purchasing an additional 14,587 shares in the last quarter. Finally, Williams & Novak LLC purchased a new position in InfuSystem during the third quarter valued at $70,000. 71.13% of the stock is owned by institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.